{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:37:07Z","timestamp":1790095027879,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann. Intensive Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Invasive pulmonary aspergillosis (IPA) has always been a challenging diagnosis and risk factors an important guide to investigate specific population, especially in Intensive Care Unit. Traditionally recognized risk factors for IPA have been haematological diseases or condition associated with severe immunosuppression, lately completed by chronic conditions (such as obstructive pulmonary disease, liver cirrhosis, chronic kidney disease and diabetes), influenza infection and Intensive Care Unit (ICU) admission. Recently, a new association with SARS-CoV2 infection, named COVID-19-associated pulmonary aspergillosis (CAPA), has been reported worldwide, even if its basic epidemiological characteristics have not been completely established yet. In this narrative review, we aimed to explore the potential risk factors for the development of CAPA and to evaluate whether previous host factors or therapeutic approaches used in the treatment of COVID-19 critically ill patients (such as mechanical ventilation, intensive care management, corticosteroids, broad-spectrum antibiotics, immunomodulatory agents) may impact this new diagnostic category. Reviewing all English-language articles published from December 2019 to December 2020, we identified 21 papers describing risk factors, concerning host comorbidities, ICU management, and COVID-19 therapies. Although limited by the quality of the available literature, data seem to confirm the role of previous host risk factors, especially respiratory diseases. However, the attention is shifting from patients\u2019 related risk factors to factors characterizing the hospital and intensive care course, deeply influenced by specific features of COVID treatment itself. Prolonged invasive or non-invasive respiratory support, as well as the impact of corticosteroids and\/or immunobiological therapies seem to play a pivotal role. ICU setting related factors, such as environmental factors, isolation conditions, ventilation systems, building renovation works, and temporal spread with respect to pandemic waves, need to be considered. Large, prospective studies based on new risk factors specific for CAPA are warranted to guide surveillance and decision of when and how to treat this particular population.<\/jats:p>","DOI":"10.1186\/s13613-021-00923-4","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T06:04:18Z","timestamp":1631685858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9341-965X","authenticated-orcid":false,"given":"G.","family":"Montrucchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lupia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Stroffolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Corcione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. G.","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Brazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"issue":"10","key":"923_CR1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","volume":"6","author":"AFAD Schauwvlieghe","year":"2018","unstructured":"Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782\u201392. https:\/\/doi.org\/10.1016\/S2213-2600(18)30274-1.","journal-title":"Lancet Respir Med"},{"issue":"SUPPL. 1","key":"923_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/13693786.2010.505204","volume":"49","author":"JW Baddley","year":"2011","unstructured":"Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol. 2011;49(SUPPL. 1):7\u201312. https:\/\/doi.org\/10.3109\/13693786.2010.505204.","journal-title":"Med Mycol"},{"issue":"1","key":"923_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","volume":"186","author":"SI Blot","year":"2012","unstructured":"Blot SI, Taccone FS, Van Den Abeele AM, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186(1):56\u201364. https:\/\/doi.org\/10.1164\/rccm.201111-1978OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"923_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"J Donnelly Peter","year":"2020","unstructured":"Donnelly Peter J, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367\u201376. https:\/\/doi.org\/10.1093\/cid\/ciz1008.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"923_CR5","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","volume":"38","author":"J Wauters","year":"2012","unstructured":"Wauters J, Baar I, Meersseman P, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med. 2012;38(11):1761\u20138. https:\/\/doi.org\/10.1007\/s00134-012-2673-2.","journal-title":"Intensive Care Med"},{"key":"923_CR6","unstructured":"COVID-19 Map - Johns Hopkins Coronavirus Resource Center. Accessed 29 Apr 2021. https:\/\/coronavirus.jhu.edu\/map.html"},{"key":"923_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","volume":"54","author":"VJ Costela-Ruiz","year":"2020","unstructured":"Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodr\u00edguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62\u201375. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.06.001.","journal-title":"Cytokine Growth Factor Rev"},{"key":"923_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.624483","volume":"11","author":"FJ Gil-Etayo","year":"2021","unstructured":"Gil-Etayo FJ, Su\u00e0rez-Fern\u00e1ndez P, Cabrera-Marante O, et al. T-helper cell subset response is a determining factor in COVID-19 progression. Front Cell Infect Microbiol. 2021;11: 624483. https:\/\/doi.org\/10.3389\/fcimb.2021.624483.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"923_CR9","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620\u20139. https:\/\/doi.org\/10.1172\/JCI137244.","journal-title":"J Clin Invest"},{"key":"923_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30847-1","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021. https:\/\/doi.org\/10.1016\/S1473-3099(20)30847-1.","journal-title":"Lancet Infect Dis"},{"key":"923_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1065","author":"M Bartoletti","year":"2020","unstructured":"Bartoletti M, Pascale R, Cricca M, et al. Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1065.","journal-title":"Clin Infect Dis"},{"key":"923_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1298","author":"PL White","year":"2020","unstructured":"White PL, Dhillon R, Cordey A, et al. A national strategy to diagnose coronavirus disease 2019\u2014associated invasive fungal disease in the intensive care unit. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1298.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"923_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/myc.13213","volume":"64","author":"M Machado","year":"2021","unstructured":"Machado M, Valerio M, \u00c1lvarez-Ur\u00eda A, et al. Invasive pulmonary aspergillosis in the COVID-19 era: an expected new entity. Mycoses. 2021;64(2):132\u201343. https:\/\/doi.org\/10.1111\/myc.13213.","journal-title":"Mycoses"},{"issue":"11","key":"923_CR14","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/myc.13155","volume":"63","author":"I Falces-Romero","year":"2020","unstructured":"Falces-Romero I, Ruiz-Basti\u00e1n M, D\u00edaz-Poll\u00e1n B, et al. Isolation of Aspergillus spp. in respiratory samples of patients with COVID-19 in a Spanish Tertiary Care Hospital. Mycoses. 2020;63(11):1144\u20138. https:\/\/doi.org\/10.1111\/myc.13155.","journal-title":"Mycoses"},{"issue":"1","key":"923_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","volume":"202","author":"ALE van Arkel","year":"2020","unstructured":"van Arkel ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, Verweij PE, Bentvelsen RG. COVID-19-associated pulmonary aspergillosis. Am J Respir Crit Care Med. 2020;202(1):132\u20135. https:\/\/doi.org\/10.1164\/rccm.202004-1038LE.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"923_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/rccm.202005-2018LE","volume":"202","author":"S Van Biesen","year":"2020","unstructured":"Van Biesen S, Kwa D, Bosman RJ, Juffermans NP. Detection of invasive pulmonary aspergillosis in COVID-19 with nondirected BAL. Am J Respir Crit Care Med. 2020;202(8):1171\u20133. https:\/\/doi.org\/10.1164\/rccm.202005-2018LE.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"923_CR17","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1164\/rccm.202005-1945LE","volume":"202","author":"A Fekkar","year":"2020","unstructured":"Fekkar A, Poignon C, Blaize M, Lampros A. Fungal infection during COVID-19: does aspergillus mean secondary invasive aspergillosis? Am J Respir Crit Care Med. 2020;202(6):902\u20133. https:\/\/doi.org\/10.1164\/rccm.202005-1945LE.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"923_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jmii.2020.09.004","volume":"54","author":"CC Lai","year":"2021","unstructured":"Lai CC, Yu WL. COVID-19 associated with pulmonary aspergillosis: a literature review. J Microbiol Immunol Infect. 2021;54(1):46\u201353. https:\/\/doi.org\/10.1016\/j.jmii.2020.09.004.","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"923_CR19","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","volume":"8","author":"A Alanio","year":"2020","unstructured":"Alanio A, Delli\u00e8re S, Fodil S, Bretagne S, M\u00e9garbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020;8(6):e48\u20139. https:\/\/doi.org\/10.1016\/S2213-2600(20)30237-X.","journal-title":"Lancet Respir Med"},{"issue":"10223","key":"923_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7.","journal-title":"Lancet"},{"issue":"4","key":"923_CR21","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1093\/cid\/ciaa001","volume":"71","author":"A Pourbaix","year":"2020","unstructured":"Pourbaix A, Lafont Rapnouil B, Gu\u00e9ry R, Lanternier F, Lortholary O, Cohen JF. Smoking as a risk factor of invasive fungal disease: systematic review and meta-analysis. Clin Infect Dis. 2020;71(4):1106\u201319. https:\/\/doi.org\/10.1093\/cid\/ciaa001.","journal-title":"Clin Infect Dis"},{"issue":"April","key":"923_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mmcr.2020.05.001","volume":"31","author":"J Prattes","year":"2021","unstructured":"Prattes J, Valentin T, Hoenigl M, Talakic E, Reisinger AC, Eller P. Invasive pulmonary aspergillosis complicating COVID-19 in the ICU\u2014a case report. Med Mycol Case Rep. 2021;31(April):2\u20135. https:\/\/doi.org\/10.1016\/j.mmcr.2020.05.001.","journal-title":"Med Mycol Case Rep"},{"issue":"6","key":"923_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1473-3099(20)30200-0","volume":"20","author":"F-X Lescure","year":"2020","unstructured":"Lescure F-X, Bouadma L, Nguyen D, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020;20(6):697\u2013706. https:\/\/doi.org\/10.1016\/S1473-3099(20)30200-0.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"923_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof6030105","volume":"6","author":"JP Gangneux","year":"2020","unstructured":"Gangneux JP, Reizine F, Guegan H, et al. Is the covid-19 pandemic a good time to include aspergillus molecular detection to categorize aspergillosis in icu patients? A monocentric experience. J Fungi. 2020;6(3):1\u201312. https:\/\/doi.org\/10.3390\/jof6030105.","journal-title":"J Fungi"},{"issue":"1","key":"923_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13613-020-00686-4","volume":"10","author":"L Rutsaert","year":"2020","unstructured":"Rutsaert L, Steinfort N, Van Hunsel T, et al. COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care. 2020;10(1):3. https:\/\/doi.org\/10.1186\/s13613-020-00686-4.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"923_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/mmy\/myaa078","volume":"59","author":"D Dupont","year":"2021","unstructured":"Dupont D, Menotti J, Turc J, et al. Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (Covid-19). Med Mycol. 2021;59(1):110\u20134. https:\/\/doi.org\/10.1093\/mmy\/myaa078.","journal-title":"Med Mycol"},{"key":"923_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2020.e00935","author":"S Abdalla","year":"2020","unstructured":"Abdalla S, Almaslamani MA, Hashim SM, Ibrahim AS, Omrani AS. Fatal coronavirus disease 2019-associated pulmonary aspergillosis; a report of two cases and review of the literature. IDCases. 2020. https:\/\/doi.org\/10.1016\/j.idcr.2020.e00935.","journal-title":"IDCases."},{"issue":"1","key":"923_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13054-020-03046-7","volume":"24","author":"J Wang","year":"2020","unstructured":"Wang J, Yang Q, Zhang P, et al. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series. Crit Care. 2020;24(1):2\u20135. https:\/\/doi.org\/10.1186\/s13054-020-03046-7.","journal-title":"Crit Care"},{"issue":"1","key":"923_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3201\/eid2701.202896","volume":"27","author":"KA Marr","year":"2021","unstructured":"Marr KA, Platt A, Tornheim JA, et al. Aspergillosis complicating severe coronavirus disease. Emerg Infect Dis. 2021;27(1):18\u201325. https:\/\/doi.org\/10.3201\/eid2701.202896.","journal-title":"Emerg Infect Dis"},{"key":"923_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcrc.2020.07.002","volume":"59","author":"AW Flikweert","year":"2020","unstructured":"Flikweert AW, Grootenboers MJJH, Yick DCY, et al. Late histopathologic characteristics of critically ill COVID-19 patients: different phenotypes without evidence of invasive aspergillosis, a case series. J Crit Care. 2020;59:149\u201355. https:\/\/doi.org\/10.1016\/j.jcrc.2020.07.002.","journal-title":"J Crit Care"},{"issue":"12","key":"923_CR31","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/myc.13185","volume":"63","author":"H Mitaka","year":"2020","unstructured":"Mitaka H, Perlman DC, Javaid W, Salomon N. Putative invasive pulmonary aspergillosis in critically ill patients with COVID-19: an observational study from New York City. Mycoses. 2020;63(12):1368\u201372. https:\/\/doi.org\/10.1111\/myc.13185.","journal-title":"Mycoses"},{"issue":"12","key":"923_CR32","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.cmi.2020.07.010","volume":"26","author":"F Lamoth","year":"2020","unstructured":"Lamoth F, Glampedakis E, Boillat-Blanco N, Oddo M, Pagani JL. Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients. Clin Microbiol Infect. 2020;26(12):1706\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.010.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"923_CR33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/myc.13135","volume":"63","author":"N Nasir","year":"2020","unstructured":"Nasir N, Farooqi J, Mahmood SF, Jabeen K. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: an observational study from Pakistan. Mycoses. 2020;63(8):766\u201370. https:\/\/doi.org\/10.1111\/myc.13135.","journal-title":"Mycoses"},{"issue":"4","key":"923_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10096-020-04063-8","volume":"40","author":"K Rothe","year":"2021","unstructured":"Rothe K, Feihl S, Schneider J, et al. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis. 2021;40(4):859\u201369. https:\/\/doi.org\/10.1007\/s10096-020-04063-8.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"923_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cmi.2020.07.047","volume":"27","author":"M Helleberg","year":"2021","unstructured":"Helleberg M, Steensen M, Arendrup MC. Invasive aspergillosis in patients with severe COVID-19 pneumonia. Clin Microbiol Infect. 2021;27(1):147\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.047.","journal-title":"Clin Microbiol Infect"},{"key":"923_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03221-w","author":"P Ichai","year":"2020","unstructured":"Ichai P, Saliba F, Baune P, Daoud A, Coilly A, Samuel D. Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients. Crit Care. 2020. https:\/\/doi.org\/10.1186\/s13054-020-03221-w.","journal-title":"Crit Care"},{"key":"923_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10100807","author":"A Apostolopoulou","year":"2020","unstructured":"Apostolopoulou A, Garrigos ZE, Vijayvargiya P, Lerner AH, Farmakiotis D. Invasive pulmonary aspergillosis in patients with SARS-CoV-2 infection: a systematic review of the literature. Diagnostics. 2020. https:\/\/doi.org\/10.3390\/diagnostics10100807.","journal-title":"Diagnostics"},{"key":"923_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-020-01057-x","author":"LF Drager","year":"2020","unstructured":"Drager LF, Pio-Abreu A, Lopes RD, Bortolotto LA. Is hypertension a real risk factor for poor prognosis in the COVID-19 pandemic? Curr Hypertens Rep. 2020. https:\/\/doi.org\/10.1007\/s11906-020-01057-x.","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"923_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1086\/518852","volume":"45","author":"W Meersseman","year":"2007","unstructured":"Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis. 2007;45(2):205\u201316. https:\/\/doi.org\/10.1086\/518852.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"923_CR40","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1164\/rccm.202006-2605ED","volume":"208","author":"A Torres","year":"2020","unstructured":"Torres A, Martin-Loeches I. Invasive pulmonary aspergillosis in ventilator-associated pneumonia: the hidden enemy? Am J Respir Crit Care Med. 2020;208(8):1071\u20133. https:\/\/doi.org\/10.1164\/rccm.202006-2605ED.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"923_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-014-0722-7","volume":"19","author":"FS Taccone","year":"2015","unstructured":"Taccone FS, Van den Abeele AM, Bulpa P, et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care. 2015;19(1):1\u201315. https:\/\/doi.org\/10.1186\/s13054-014-0722-7.","journal-title":"Crit Care"},{"issue":"8","key":"923_CR42","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","volume":"46","author":"PE Verweij","year":"2020","unstructured":"Verweij PE, Rijnders BJA, Br\u00fcggemann RJM, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46(8):1524\u201335. https:\/\/doi.org\/10.1007\/s00134-020-06091-6.","journal-title":"Intensive Care Med"},{"issue":"2","key":"923_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof6020091","volume":"6","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A, Carvalho A, van de Veerdonk FL, et al. COVID-19 associated pulmonary aspergillosis (CAPA)\u2014from immunology to treatment. J Fungi. 2020;6(2):1\u201317. https:\/\/doi.org\/10.3390\/jof6020091.","journal-title":"J Fungi"},{"issue":"8","key":"923_CR44","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/nejmoa2021436","volume":"384","author":"Group TR","year":"2021","unstructured":"Group TR. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704. https:\/\/doi.org\/10.1056\/nejmoa2021436.","journal-title":"N Engl J Med"},{"issue":"10","key":"923_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/eci.13319","volume":"50","author":"DR Giacobbe","year":"2020","unstructured":"Giacobbe DR, Battaglini D, Ball L, et al. Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2020;50(10):1\u20138. https:\/\/doi.org\/10.1111\/eci.13319.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"923_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4415\/ANN_20_03_14","volume":"56","author":"L Fattorini","year":"2020","unstructured":"Fattorini L, Creti R, Palma C, et al. Bacterial coinfections in COVID-19: an underestimated adversary. Ann Ist Super Sanita. 2020;56(3):359\u201364. https:\/\/doi.org\/10.4415\/ANN_20_03_14.","journal-title":"Ann Ist Super Sanita"},{"key":"923_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab065","author":"CJ Clancy","year":"2021","unstructured":"Clancy CJ, Schwartz IS, Kula B, Nguyen MH. Bacterial superinfections among persons with coronavirus disease 2019: a comprehensive review of data from postmortem studies. Open Forum Infect Dis. 2021. https:\/\/doi.org\/10.1093\/ofid\/ofab065.","journal-title":"Open Forum Infect Dis"},{"key":"923_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab163","author":"F Lamoth","year":"2021","unstructured":"Lamoth F, Lewis RE, Walsh TJ, Kontoyiannis DP. Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): a comparison with influenza associated aspergillosis (IAPA). J Infect Dis. 2021. https:\/\/doi.org\/10.1093\/infdis\/jiab163.","journal-title":"J Infect Dis"},{"issue":"5","key":"923_CR49","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/jof7050388","volume":"7","author":"F Reizine","year":"2021","unstructured":"Reizine F, Pinceaux K, Lederlin M, et al. Influenza- and COVID-19-associated pulmonary aspergillosis: are the pictures different? J Fungi (Basel). 2021;7(5):388. https:\/\/doi.org\/10.3390\/jof7050388.","journal-title":"J Fungi (Basel)."},{"issue":"1","key":"923_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13054-020-03221-w","volume":"24","author":"P Ichai","year":"2020","unstructured":"Ichai P, Saliba F, Baune P, Daoud A, Coilly A, Samuel D. Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients. Crit Care. 2020;24(1):4\u20136. https:\/\/doi.org\/10.1186\/s13054-020-03221-w.","journal-title":"Crit Care"},{"issue":"1","key":"923_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13054-020-03062-7","volume":"24","author":"S Pons","year":"2020","unstructured":"Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24(1):353. https:\/\/doi.org\/10.1186\/s13054-020-03062-7.","journal-title":"Crit Care"},{"issue":"49","key":"923_CR52","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/sciimmunol.abd1554","volume":"5","author":"JS Lee","year":"2020","unstructured":"Lee JS, Park S, Jeong HW, et al. Immunophenotyping of covid-19 and influenza highlights the role of type i interferons in development of severe covid-19. Sci Immunol. 2020;5(49):1554. https:\/\/doi.org\/10.1126\/sciimmunol.abd1554.","journal-title":"Sci Immunol"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-021-00923-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-021-00923-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-021-00923-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:41:04Z","timestamp":1767768064000},"score":1,"resource":{"primary":{"URL":"https:\/\/annalsofintensivecare.springeropen.com\/articles\/10.1186\/s13613-021-00923-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["923"],"URL":"https:\/\/doi.org\/10.1186\/s13613-021-00923-4","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"26 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest related to the present work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}